# Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

> **NCT04098302** · PHASE2,PHASE3 · COMPLETED · sponsor: **UConn Health** · enrollment: 180 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Dutasteride Capsules
- **DRUG:** Placebo Capsules

## Key facts

- **NCT ID:** NCT04098302
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-15
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-06-28
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04098302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04098302, "Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04098302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*